Share
Market Research Report

U.S. INJECTABLE COMPOUNDING PHARMACY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By MoleculeAcetaminophen · Phenylephrine · Midazolam · Esmolol · Vancomycin · Epinephrine · Adenocaine · Fentanyl/Bupivacaine · Morphine · Amiodarone · Fentanyl · Heparin · Ketamine · Dextrose · Hydromorphone · Bupivacaine · Lidocaine · BKK (Bupivacaine, Ketorolac, Ketamine) · RCK (Ropivacaine, Clonidine, Ketorolac) · RKK (Ropivacaine, Ketorolac, Ketamine) · Norepinephrine · Diltiazem · Vasopressin · Others
  • By Packaging TypeVials · Ampoules · Prefilled Syringes · Others
  • By Pharmacy Type503A Pharmacies · 503B Pharmacies
  • Published In25 Mar 2025
  • Report CodeCMI4478
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2025
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Molecule
      • Market Snippet, By Packaging Type
      • Market Snippet, By Pharmacy Type
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Recent Product Approvals/Launches
    • Mergers, Acquisitions, and Collaborations
    • Regulatory Scenario
    • Recent Trends
    • Key Developments
    • PEST Analysis
    • Porter’s Analysis
  4. U.S. Injectable Compounding Pharmacy Market

    • Economic Impact
    • Impact on Supply and Demand
  5. U.S. Injectable Compounding Pharmacy Market, By Molecule, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Acetaminophen 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Phenylephrine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Midazolam 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Esmolol
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Vancomycin 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Epinephrine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Adenocaine 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Fentanyl/Bupivacaine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Morphine 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Amiodarone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Fentanyl 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Heparin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Ketamine 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Dextrose
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Hydromorphone 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Bupivacaine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Lidocaine 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • BKK (Bupivacaine, Ketorolac, Ketamine)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • RCK (Ropivacaine, Clonidine, Ketorolac) 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • RKK (Ropivacaine, Ketorolac, Ketamine)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Norepinephrine 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Diltiazem
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Vasopressin 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
  6. U.S. Injectable Compounding Pharmacy Market, By Packaging Type, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Vials
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Ampoules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Prefilled Syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
  7. U.S. Injectable Compounding Pharmacy Market, By Pharmacy Type, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • 503A Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
    • 503B Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
      • Segment Trends
  8. Competitive Landscape

    • Company Profiles
      • Central Admixture Pharmacy Services, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Nephron Pharmaceuticals Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • QuVa Pharma
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Olympia Pharmacy
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • ASP Cares
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Fagron Compounding Pharmacies
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Athenex, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Avella Specialty Pharmacy
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Atlas Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Empower Pharmacy
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Carie Boyd’S Prescription Shop
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Edge Pharma
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Imprimis NJOF, LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • IntegraDose Compounding Services, LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Wells Pharma of Houston, LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • US Compounding Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • SCA Pharma
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Leiters Health
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Medivant Healthcare
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Vertisis Custom Pharmacy
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Analysts’ Views
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 9 market data tables and 37 figures on “U.S. Injectable Compounding Pharmacy Market” - Global forecast to 2033